# Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

> **NCT00729911** · PHASE4 · COMPLETED · sponsor: **Texas Cardiac Arrhythmia Research Foundation** · enrollment: 203 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **PROCEDURE:** Atrial Fibrillation ablation
- **DRUG:** Amiodarone

## Key facts

- **NCT ID:** NCT00729911
- **Lead sponsor:** Texas Cardiac Arrhythmia Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2019-04-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00729911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00729911, "Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00729911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*